Oruka Therapeutics, Inc. financial statements
Oruka Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 0 | EODHD |
| Net income | −USD 105.43M | 10-K |
| Cash and equivalents | USD 46.94M | 10-Q |
| Total debt | USD 1.93M | EODHD |
Oruka Therapeutics, Inc. financials on 6ix · Oruka Therapeutics, Inc. on 6ix